Pangali rega marang bathi Intra-Cellular Therapies Inc. (ITCI)
Intra-Cellular Therapies (ITCI) relies on predictable revenues from bipolar disorder and schizophrenia therapies, ensuring stable cash flows. The company's competitive advantages are guaranteed by robust patent protection and recognition within the professional psychiatric community. This price action chart on GURU.Markets shows a PE ratio of -185.50, driven by a sharp surge in profits from the sale of its primary drug and high investor expectations.
Rincian analitis perusahaan Intra-Cellular Therapies Inc. (ITCI)
- nilai pasar lan prakiraan target analis:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Intra-Cellular Therapies|ITCI - Rasio utang jangka dawa marang ekuitas|Tanggungan utang jangka cendhak marang ekuitas Intra-Cellular|ITCI - Gunggung utang perusahaan|Utang marang nilai buku Intra-Cellular Therapies, Inc.|ITCI - Utang jangka dawa perusahaan|Utang jangka cendhak Intra-Cellular Therapies|Likuiditas cepet intracellulartherapies.com
- informasi bathi lan kelipatan valuasi:
ITCI - Bathi resik perusahaan|Bathi sing dikarepake Intra-Cellular Therapies|ITCI - Koefisien rega marang bathi|Pangali Forward P/E Intra-Cellular|ITCI - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Intra-Cellular Therapies, Inc.|ITCI - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Intra-Cellular Therapies|ITCI - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan intracellulartherapies.com|ITCI - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Intra-Cellular Therapies
Ringkesan analisis perusahaan:ITCI intracellulartherapies.com
This metric is calculated as the ratio of market capitalization to net income, reflecting the sensitivity of business value to operational efficiency. This ratio measures the investment payback period based on current profitability. For Intra-Cellular Therapies (ITCI), it depends critically on Caplyta commercial sales and regulatory price caps. Any margin compression resulting from patent risks will be immediately reflected in the valuation. By analyzing the current P/E multiple, an investor can distinguish fundamental undervaluation from a systemic decline in revenue.
Pesaing wigati
biogen.com (BIIB) - Periode bali modal bisnis|Rasio rega marang bathi Neurocrine Biosciences, Inc. (NBIX)|Regencell Bioscience Ltd - Pangali rega marang bathi|Axsome Therapeutics Inc - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik ACAD (ACADIA Corp)|XENE - Rasio rega marang bathi|Nilai perusahaan marang bathi resik VKTX (vikingtherapeutics.com)|SUPN: Pangali P/E|Catalyst Pharma (CPRX) - Pangali P/E|Koefisien rega marang bathi DNLI|HRMY - Rasio kapitalisasi marang bathi resik|Pangali P/E BHVN|Koefisien rega marang bathi amylyx.com AMLX|Pangali P/E TRVI (Trevi Therapeutics, Inc.)|Praxis Precision Medicines Inc (PRAX) - Kapitalisasi marang bathi|AVXL - Rasio rega marang bathi|CBLL: Rasio rega marang bathi|prothena.com (PRTA) - Rasio rega marang bathi|ALEC (Alector) - Rasio rega marang bathi|Koefisien rega marang bathi ANNX|Pangali P/E Omeros Corp.|Rasio rega marang bathi Neurogene Corp (NGNE)|Rasio rega marang bathi ACIU (AC Immune Inc)|Pangali P/E VYGR (Voyager Therapeutics)|Pangali P/E neumoratx.com NMRA|SCLX - Rasio rega marang bathi|Nilai perusahaan marang bathi resik TVGN (Tevogen Bio Holdings Inc.)|ACOG (alphacognition.com) - Koefisien rega marang bathi|Cognition Therapeutics Inc. - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi IKT|SAVA (cassavasciences.com) - Rasio rega pasar marang bathi resik|Pangali P/E ASRT|COYA (coyatherapeutics.com) - Nilai perusahaan marang bathi resik|Pangali P/E VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Kapitalisasi marang bathi|ABOS - Rasio rega marang bathi|Nilai perusahaan marang bathi resik CRVO (cervomed.com)|ATHE: Pangali P/E|Clene (CLNN) - Pangali P/E|Rasio rega marang bathi PepGen Inc|Jupiter Neurosciences, Inc. - Kapitalisasi marang bathi resik|Pangali P/E RLMD|Periode bali modal bisnis annovisbio.com|Pangali P/E GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Kapitalisasi marang bathi|KLTO - Rasio rega marang bathi|Periode bali modal bisnis NeuroSense Therapeutics NRSN|RVPH: Pangali P/E|MTVA - Periode bali modal bisnis|Koefisien rega marang bathi NRXS|HSDT (Helius Medical Technologies Inc.) - Rasio rega pasar marang bathi resik|Pangali P/E PASG|Koefisien rega marang bathi bionomics.com.au NEUP|Pangali P/E NERV (Minerva Neurosciences)|Periode bali modal bisnis athira.com (ATHA)|ADXN - Rasio rega marang bathi|ALZN (Alzamend Neuro, Inc.) - Pangali rega marang bathi|CYCN: Pangali P/E|Kapitalisasi marang bathi Protagenic Therapeutics, Inc. (PTIX)|Koefisien rega marang bathi KTTA|Pangali P/E Cortigent Medical|Rasio rega marang bathi Avenue Therapeutics, Inc. (ATXI)|BCLI (Brainstorm Cell Therapeutics Inc.) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Cara Therapeutics, Inc CARA|Chromocell (CHRO) - Kapitalisasi marang bathi|Eliem - Pangali P/E|Periode bali modal bisnis longboardpharma.com LBPH|Marinus Pharmaceuticals, Inc. (MRNS) - Rasio rega marang bathi|Pangali rega marang bathi NKGN|Koefisien rega marang bathi NRBO|SAGE (Sage Therapeutics Inc) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi Synaptogenix, Inc. (SNPX)|TRVN (trevena.com) - Nilai perusahaan marang bathi resik|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|Pangali P/E anewmeds.com WENA|CERE: Koefisien rega marang bathi
